Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9341585 | 1.00 | AMY1A (0.56) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL30374717 | 1.00 | AMY1A (0.56) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL28675364 | 0.94 | AMY1A (0.50) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL17666370 | 0.90 | ALDH1A1 (0.59) | AMY1ACYP2C19HSD17B10ALDH1A1HSPA5 | |
| SCHEMBL21232598 | 0.89 | AMY1A (0.54) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL6732004 | 0.89 | ALDH1A1 (0.48) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL68936 | 0.88 | ALDH1A1 (0.62) | CYP2C19HSD17B10ALDH1A1HSPA5GABRA1 | |
| SCHEMBL11820175 | 0.86 | AMY1A (0.58) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL3027866 | 0.86 | AMY1A (0.58) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 | |
| SCHEMBL20169592 | 0.84 | AMY1A (0.41) | AMY1ACYP2C9CYP2C19HIF1ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113646052-B | Reversible thermochromic composition, reversible thermochromic microcapsule pigment, and writing instrument | 百乐墨水株式会社 | 2024-05-17 | — | — | CN | disclosed |
| EP-3498788-B1 | SOLDER MASK INKJET INKS FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA GEVAERT NV (BE) | 2023-05-03 | — | — | EP | disclosed |
| US-20220411654-A1 | Radiation Curable Inkjet Ink for Manufacturing Printed Circuit Boards | AGFA-GEVAERT NV (BE) | 2022-12-29 | — | — | US | disclosed |
| US-20220025199-A1 | RADIATION CURABLE INKJET INK FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA-GEVAERT NV (BE) | 2022-01-27 | — | — | US | disclosed |
| US-20220010156-A1 | RADIATION CURABLE INKJET INK FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA-GEVAERT NV (BE) | 2022-01-13 | — | — | US | disclosed |
| US-20210403738-A1 | NOVEL PHOTOINITIATORS | AGFA-GEVAERT NV (BE) | 2021-12-30 | — | — | US | disclosed |
| CN-113646052-A | Reversible thermal discoloration composition, reversible thermal discoloration microcapsule pigment encapsulating the reversible thermal discoloration composition, and writing instrument using the reversible thermal discoloration microcapsule pigment | 百乐墨水株式会社 | 2021-11-12 | — | — | CN | disclosed |
| US-20200332140-A1 | SOLDER MASK INKJET INKS FOR MANUFACTURING PRINTED CIRCUIT BOARDS | ELECTRA POLYMER LTD. (GB) | 2020-10-22 | — | — | US | disclosed |
| EP-3686252-A1 | RADIATION CURABLE INKJET INK FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA-GEVAERT NV (BE) | 2020-07-29 | — | — | EP | disclosed |
| EP-3656824-A1 | RADIATION CURABLE INKJET FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA-GEVAERT NV (BE) | 2020-05-27 | — | — | EP | disclosed |
| EP-3498788-A1 | SOLDER MASK INKJET INKS FOR MANUFACTURING PRINTED CIRCUIT BOARDS | Agfa-Gevaert (BE) | 2019-06-19 | — | — | EP | disclosed |
| WO-2018087056-A1 | SOLDER MASK INKJET INKS FOR MANUFACTURING PRINTED CIRCUIT BOARDS | AGFA-GEVAERT N.V. (BE) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210403738-A1 | NOVEL PHOTOINITIATORS | AGK, AASDHPPT, BCKDK | AMY1A 2732/4885CYP2C9 2348/4885CYP2C19 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.